The most prevalent Long Covid symptoms — crippling fatigue, post-exertional malaise and cognitive dysfunction — mirror those of ME/CFS and both are post-viral illnesses. We believe that learning more about Long Covid can deepen our understanding of ME/CFS, and that what we know about ME/CFS can shed light on Long Covid — and ultimately point to treatments and cures for both, as well as other long haul diseases that share their characteristics. 

Solve M.E. embraces and supports many post-infectious chronic disease communities, such as: ME/CFS, Long Covid, postural orthostatic tachycardia syndrome (POTS), other forms of dysautonomia, Ehlers-Danlos Syndrome (EDS), hypermobility spectrum disorder (HSD), and mast cell activation syndrome (MCAS). It has been our mission to increase federal funding dollars and research solutions that will make ME/CFS, Long Covid, and other “long haul” diseases more diagnosable, better understood, and treatable. 

We co-founded the Long COVID Alliance in February 2021, and expanded our advocacy efforts beyond ME/CFS to educate policymakers and accelerate research to address the emerging challenges facing those with ME/CFS, Long Covid and related “long haul” diseases. Solve M.E also opened Solve Together to include Long Covid and expanded our Ramsay Research Grant program to include the study of Long Covid. Both will help researchers track conditions similar to ME/CFS and other post-infectious diseases from onset, helping us to understand the effects of viral diseases on the immune system.

With our considerable research and advocacy experience, Solve M.E. has been a leader in the fight against post-infection diseases like Long Covid for nearly 40 years. In December 2021, we launched our Long Covid Initiative to strengthen our response to this emerging crisis while ensuring that progress made will benefit everyone with a “long haul” disease.